Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.6
(0.0%)
HKD 5.6
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.31 Billion CNY | 8.33% |
| 2022 | 1.21 Billion CNY | 17.95% |
| 2021 | 1.02 Billion CNY | -8.61% |
| 2020 | 1.12 Billion CNY | -0.53% |
| 2019 | 1.13 Billion CNY | 18.77% |
| 2018 | 951.72 Million CNY | 33.44% |
| 2017 | 713.21 Million CNY | 27.48% |
| 2016 | 559.48 Million CNY | 2.38% |
| 2015 | 546.46 Million CNY | -7.2% |
| 2014 | 588.88 Million CNY | 10.69% |
| 2013 | 531.99 Million CNY | 8.64% |
| 2012 | 489.67 Million CNY | 15.55% |
| 2011 | 423.78 Million CNY | 5.54% |
| 2010 | 401.54 Million CNY | 16.65% |
| 2009 | 344.21 Million CNY | 13.04% |
| 2008 | 304.51 Million CNY | 6.46% |
| 2007 | 286.04 Million CNY | 27.49% |
| 2006 | 224.35 Million CNY | -18.35% |
| 2005 | 274.76 Million CNY | -8.49% |
| 2004 | 300.25 Million CNY | 19.84% |
| 2003 | 250.53 Million CNY | 13.48% |
| 2002 | 220.77 Million CNY | 11.73% |
| 2001 | 197.59 Million CNY | 18.94% |
| 2000 | 166.12 Million CNY | -7.46% |
| 1999 | 179.51 Million CNY | -0.44% |
| 1998 | 180.31 Million CNY | -9.08% |
| 1997 | 198.31 Million CNY | 7.56% |
| 1996 | 184.37 Million CNY | 15.08% |
| 1995 | 160.21 Million CNY | 5.84% |
| 1994 | 151.38 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.13 Billion CNY | -13.7% |
| 2024 Q3 | 1.26 Billion CNY | 6.19% |
| 2024 Q2 | 1.19 Billion CNY | 5.16% |
| 2023 FY | 1.31 Billion CNY | 8.33% |
| 2023 Q1 | 969.46 Million CNY | -20.01% |
| 2023 Q2 | 1.01 Billion CNY | 4.26% |
| 2023 Q4 | 1.31 Billion CNY | 35.25% |
| 2023 Q3 | 970.74 Million CNY | -3.96% |
| 2022 FY | 1.21 Billion CNY | 17.95% |
| 2022 Q1 | 846.58 Million CNY | -17.61% |
| 2022 Q4 | 1.21 Billion CNY | 24.92% |
| 2022 Q2 | 1.03 Billion CNY | 22.27% |
| 2022 Q3 | 970.17 Million CNY | -6.28% |
| 2021 FY | 1.02 Billion CNY | -8.61% |
| 2021 Q1 | 914.86 Million CNY | -18.63% |
| 2021 Q2 | 844.46 Million CNY | -7.7% |
| 2021 Q3 | 901.65 Million CNY | 6.77% |
| 2021 Q4 | 1.02 Billion CNY | 13.96% |
| 2020 Q4 | 1.12 Billion CNY | 37.32% |
| 2020 Q3 | 818.81 Million CNY | 3.87% |
| 2020 Q2 | 788.3 Million CNY | -2.7% |
| 2020 Q1 | 810.17 Million CNY | -28.33% |
| 2020 FY | 1.12 Billion CNY | -0.53% |
| 2019 FY | 1.13 Billion CNY | 18.77% |
| 2019 Q1 | 793.25 Million CNY | -16.65% |
| 2019 Q2 | 782.74 Million CNY | -1.32% |
| 2019 Q3 | 753.6 Million CNY | -3.72% |
| 2019 Q4 | 1.13 Billion CNY | 49.99% |
| 2018 Q2 | 670.63 Million CNY | 13.18% |
| 2018 Q3 | 657.27 Million CNY | -1.99% |
| 2018 FY | 951.72 Million CNY | 33.44% |
| 2018 Q4 | 951.72 Million CNY | 44.8% |
| 2018 Q1 | 592.53 Million CNY | -16.92% |
| 2017 FY | 713.21 Million CNY | 27.48% |
| 2017 Q4 | 713.21 Million CNY | 52.31% |
| 2017 Q3 | 468.26 Million CNY | -6.31% |
| 2017 Q2 | 499.81 Million CNY | 6.4% |
| 2017 Q1 | 469.73 Million CNY | -16.04% |
| 2016 FY | 559.48 Million CNY | 2.38% |
| 2016 Q4 | 559.48 Million CNY | 42.38% |
| 2016 Q1 | 451.65 Million CNY | -17.35% |
| 2016 Q2 | 443.21 Million CNY | -1.87% |
| 2016 Q3 | 392.96 Million CNY | -11.34% |
| 2015 Q1 | 532.31 Million CNY | -9.61% |
| 2015 Q4 | 546.46 Million CNY | 11.41% |
| 2015 FY | 546.46 Million CNY | -7.2% |
| 2015 Q3 | 490.47 Million CNY | -2.56% |
| 2015 Q2 | 503.33 Million CNY | -5.44% |
| 2014 Q1 | 463.94 Million CNY | -12.79% |
| 2014 Q3 | 480.86 Million CNY | 12.9% |
| 2014 Q4 | 588.88 Million CNY | 22.47% |
| 2014 FY | 588.88 Million CNY | 10.69% |
| 2014 Q2 | 425.93 Million CNY | -8.19% |
| 2013 Q4 | 531.99 Million CNY | 3.68% |
| 2013 FY | 531.99 Million CNY | 8.64% |
| 2013 Q3 | 513.12 Million CNY | 4.6% |
| 2013 Q2 | 490.55 Million CNY | -7.71% |
| 2013 Q1 | 531.54 Million CNY | 8.55% |
| 2012 FY | 489.67 Million CNY | 15.55% |
| 2012 Q2 | 445.93 Million CNY | 8.12% |
| 2012 Q1 | 412.42 Million CNY | -2.68% |
| 2012 Q3 | 436.77 Million CNY | -2.05% |
| 2012 Q4 | 489.67 Million CNY | 12.11% |
| 2011 Q2 | 370.24 Million CNY | 8.81% |
| 2011 FY | 423.78 Million CNY | 5.54% |
| 2011 Q4 | 423.78 Million CNY | 9.8% |
| 2011 Q3 | 385.95 Million CNY | 4.24% |
| 2011 Q1 | 340.27 Million CNY | -15.26% |
| 2010 Q2 | 309.06 Million CNY | 0.19% |
| 2010 Q3 | 280.46 Million CNY | -9.25% |
| 2010 Q4 | 401.54 Million CNY | 43.17% |
| 2010 Q1 | 308.48 Million CNY | -10.38% |
| 2010 FY | 401.54 Million CNY | 16.65% |
| 2009 Q2 | 245.77 Million CNY | -7.05% |
| 2009 FY | 344.21 Million CNY | 13.04% |
| 2009 Q3 | 252.55 Million CNY | 2.76% |
| 2009 Q1 | 264.42 Million CNY | -13.16% |
| 2009 Q4 | 344.21 Million CNY | 36.29% |
| 2008 Q2 | 270.27 Million CNY | 5.96% |
| 2008 FY | 304.51 Million CNY | 6.46% |
| 2008 Q1 | 255.07 Million CNY | -10.83% |
| 2008 Q4 | 304.51 Million CNY | 4.92% |
| 2008 Q3 | 290.23 Million CNY | 7.39% |
| 2007 FY | 286.04 Million CNY | 27.49% |
| 2007 Q3 | 216.38 Million CNY | -2.6% |
| 2007 Q1 | 207.01 Million CNY | -7.73% |
| 2007 Q2 | 222.16 Million CNY | 7.32% |
| 2007 Q4 | 286.04 Million CNY | 32.19% |
| 2006 Q2 | 242.79 Million CNY | -4.23% |
| 2006 Q1 | 253.53 Million CNY | -7.73% |
| 2006 Q4 | 224.35 Million CNY | 4.83% |
| 2006 FY | 224.35 Million CNY | -18.35% |
| 2006 Q3 | 214.01 Million CNY | -11.86% |
| 2005 Q2 | 238.67 Million CNY | -10.12% |
| 2005 Q4 | 274.76 Million CNY | 25.04% |
| 2005 Q3 | 219.74 Million CNY | -7.93% |
| 2005 Q1 | 265.55 Million CNY | -11.56% |
| 2005 FY | 274.76 Million CNY | -8.49% |
| 2004 Q4 | 300.25 Million CNY | 16.54% |
| 2004 Q1 | 240.56 Million CNY | -3.98% |
| 2004 Q3 | 257.63 Million CNY | 0.86% |
| 2004 FY | 300.25 Million CNY | 19.84% |
| 2004 Q2 | 255.43 Million CNY | 6.18% |
| 2003 FY | 250.53 Million CNY | 13.48% |
| 2003 Q1 | 216.33 Million CNY | -2.01% |
| 2003 Q2 | 225.46 Million CNY | 4.22% |
| 2003 Q3 | 229.16 Million CNY | 1.64% |
| 2003 Q4 | 250.53 Million CNY | 9.32% |
| 2002 Q3 | 205.6 Million CNY | 0.59% |
| 2002 Q1 | 206.37 Million CNY | 4.45% |
| 2002 FY | 220.77 Million CNY | 11.73% |
| 2002 Q2 | 204.41 Million CNY | -0.95% |
| 2002 Q4 | 220.77 Million CNY | 7.38% |
| 2001 Q4 | 197.59 Million CNY | 0.0% |
| 2001 Q2 | 178.24 Million CNY | 0.0% |
| 2001 FY | 197.59 Million CNY | 18.94% |
| 2000 FY | 166.12 Million CNY | -7.46% |
| 2000 Q4 | 166.12 Million CNY | 0.0% |
| 2000 Q2 | 161.21 Million CNY | 0.0% |
| 1999 FY | 179.51 Million CNY | -0.44% |
| 1999 Q4 | 179.51 Million CNY | 0.0% |
| 1999 Q2 | 173.49 Million CNY | 0.0% |
| 1998 Q4 | 180.31 Million CNY | 0.0% |
| 1998 FY | 180.31 Million CNY | -9.08% |
| 1998 Q2 | 176.77 Million CNY | 0.0% |
| 1997 Q4 | 198.31 Million CNY | 0.0% |
| 1997 FY | 198.31 Million CNY | 7.56% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 FY | 184.37 Million CNY | 15.08% |
| 1996 Q4 | 184.37 Million CNY | 0.0% |
| 1995 FY | 160.21 Million CNY | 5.84% |
| 1994 FY | 151.38 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -10664.809% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 5.449% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -17972.728% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -326.158% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -204.082% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -340.442% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -1990.009% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -1236.153% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -647.726% |
| SSY Group Limited | 1.08 Billion HKD | -20.87% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -1333.623% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -313.074% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 96.259% |